col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


192 Results       Page 1

 [1] 
Wiley: European Journal of Neurology
  original article Date Title Authors   All Authors
1 [GO] 2024―Sep―06 Impact of SARS-CoV-2 infection and COVID-19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain Pilar H. García-Casanova, Pablo Pérez-Martínez, Teresa Sevilla, Rosalía Doménech, Montserrat León, Juan F. Vázquez-Costa
2 [GO] 2024―Aug―12 A nationwide Guillain-Barré syndrome epidemiological study in Spain during the COVID-19 years Marina Blanco-Ruiz, Lorena Martín-Aguilar, Marta Caballero-Ávila, Cinta Lleixà, Elba Pascual-Goñi, Roger Collet-Vidiella, et al. (+7)
3 [GO] 2024―Aug―01 Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers - An updated European Academy of Neurology consensus statement Saša R. Filipović, Serefnur Özturk, Daniel Bereczki, Benedetta Bodini, Francesco Cavallieri, Alessandra Fanciulli, et al. (+11)
4 [GO] 2024―Jun―08 Cognitive deficits and cortical volume loss in COVID-19-related hyposmia Haşim Gezegen, Ulaş Ay, Bedia Samancı, Elif Kurt, Sanem Sultan Yörük, Alpay Medetalibeyoğlu, et al. (+7)
5 [GO] 2024―May―15 “Spanish flu,” encephalitis lethargica, and COVID-19: Progress made, lessons learned, and directions for future research Michael Brainin, Yvonne Teuschl, Ellen Gelpi
6 [GO] 2024―Apr―20 Clinical effectiveness of coronavirus disease 2019 vaccination in patients with multiple sclerosis stratified by disease-modifying treatment Marijke De Troyer, Ann Van Remoortel, Jeroen Van Schependom, Laetitia Della Faille, Marie B. D'hooghe, Gertjan Peeters, et al. (+2)
7 [GO] 2024―Apr―17 Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S Dimos-Dimtirios D. Mitsikostas, Edoardo Caronna, Marina De Tommaso, Christina I. Deligianni, Esme Ekizoglu, Hayrunnisa Bolay, et al. (+8)
8 [GO] 2024―Apr―16 Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic Josef Finsterer, Sounira Mehri
9 [GO] 2024―Feb―28 Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review Dimos-Dimtirios D. Mitsikostas, Edoardo Caronna, Marina De Tommaso, Christina I. Deligianni, Esme Ekizoglu, Hayrunnisa Bolay, et al. (+8)
10 [GO] 2024―Jan―02 Increased risk of functional neurological disorders following SARS-CoV-2 vaccination Andrea Pilotto, Marcello Catania, Irene Mattioli, Nicola Zoppi, Giulia Ceccardi, Renata Rao, et al. (+4)
11 [GO] 2023―Dec―01 The COVID-19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics Martin Rakusa, Elena F. Moro, Tamar Akhvlediani, Daniel Bereczki, Benedetta Bodini, Francesco Cavallieri, et al. (+12)
12 [GO] 2023―Nov―28 COVID-19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark Dominika Stastna, Frederik Elberling, Luigi Pontieri, Elisabeth Framke, Dana Horakova, Jiri Drahota, et al. (+2)
13 [GO] 2023―Oct―25 Neurological complications during the Omicron COVID-19 wave in China: A cohort study Lu Lu, Lei Chen, Peiyu Wang, Zhang Qi, Yujie Chen, Xintong Wu, et al. (+10)
14 [GO] 2023―Oct―12 Guillain-Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’ Stefano Censi, Giandomenico Bisaccia, Sabina Gallina, Valentina Tomassini, Antonino Uncini
15 [GO] 2023―Oct―05 COVID-19 vaccination and myasthenia gravis Anat Arbel, Haya Bishara, Ofra Barnett-Griness, Shai Cohen, Ronza Najjar-Debbiny, Naomi Gronich, et al. (+2)
16 [GO] 2023―Oct―05 COVID-19 vaccination and myasthenia gravis Amnuay Kleebayoon, Viroj Wiwanitkit
17 [GO] 2023―Oct―04 Migraine worsening after COVID-19 and COVID-19 vaccination: Are we facing a nocebo effect? Laura Melgarejo, Edoardo Caronna, Joana Rosell-Mirmi, Iker Elosua-Bayés, Alicia Alpuente, Marta Torres-Ferrus, et al. (+2)
18 [GO] 2023―Oct―03 Long COVID and cognition François Chollet, Jean-Marc Leger
19 [GO] 2023―Sep―14 Rates of John Cunningham virus seroconversion greatly reduced in natalizumab-treated patients during COVID-19-related lockdowns Chris Dwyer, Sifat Sharmin, Tomas Kalincik
20 [GO] 2023―Aug―30 Prospective follow-up study of youth and adults with onset of functional tic-like behaviours during the COVID-19 pandemic Christelle Nilles, Natalia Szejko, Davide Martino, Tamara Pringsheim
21 [GO] 2023―Aug―16 Amantadine in unvaccinated patients with early, mild to moderate COVID-19: a randomized, placebo-controlled, double-blind trial. Konrad Rejdak, Piotr Fiedor, Robert Bonek, Jacek Łukasiak, Waldemar Chełstowski, Sławomir Kiciak, et al. (+7)
22 [GO] 2023―Aug―08 Association between COVID-19 Vaccination and Myasthenia Gravis: a Population-based Nested Case Control Study Anat Arbel, Haya Bishara, Ofra Barnett-Griness, Shai Cohen, Ronza Najjar-Debbiny, Naomi Gronich, et al. (+2)
23 [GO] 2023―Aug―04 What do we mean by long-COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection Alessia Nicotra, Federico Masserini, Francesca Calcaterra, Clara Di Vito, Pietro Emiliano Doneddu, Simone Pomati, et al. (+4)
24 [GO] 2023―Aug―01 Neurological side effects and drug interactions of antiviral compounds against SARS-CoV-2 Tamar Akhvlediani, Raphael Bernard-Valnet, Sara P. Dias, Randi Eikeland, Bettina Pfausler, Johann Sellner
25 [GO] 2023―Jul―31 The impact of hybrid immunity on immune responses after SARS-CoV-2 vaccination in persons with multiple sclerosis treated with disease modifying therapies Monika Rabenstein, Olivia G. Thomas, Giorgia Carlin, Mohsen Khademi, Klara Asplund Högelin, Clas Malmeström, et al. (+9)
26 [GO] 2023―Jul―22 Effect of COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation Alice Mariottini, Antonio Lotti, Chiara Innocenti, Anna Maria Repice, Chiara Nozzoli, Riccardo Boncompagni, et al. (+3)
27 [GO] 2023―Jul―01 Myoclonus in patients with COVID-19; findings of autoantibodies against brain structures in cerebral spinal fluid Isa Lindqvist, Janet L. Cunningham, Jan Mulder, Amalia Feresiadou, Elham Rostami, Johan Virhammar, Eva Kumlien
28 [GO] 2023―Jun―13 Three to four mRNA COVID-19 vaccine in multiple sclerosis patients on immunosuppressive drugs: seroconversion and variants neutralization Céline Louapre, Lisa Belin, Stéphane Marot, Amandine Hippolyte, Edouard Januel, Michella Ibrahim, et al. (+8)
29 [GO] 2023―Jun―13 SARS-CoV-2 cannot unmask Parkinson's disease if there was none before infection Josef Finsterer, Fulvio A. Scorza
30 [GO] 2023―Jun―12 Association of multiple sclerosis-related mortality with COVID-19 and other common infections: a multiple causes of death analysis Ugo Fedeli, Claudio Barbiellini Amidei, Francesco Avossa, Elena Schievano, Elaine Kingwell
31 [GO] 2023―Jun―12 Reported neurological symptoms after severe acute respiratory syndrome coronavirus type 2 (SARS CoV-2) infection: a systematic diagnostic approach B. Ludwig, M. Deckert, N. Krajnc, O. Keritam, S. Macher, G. Bsteh, et al. (+6)
32 [GO] 2023―Jun―09 Response to “Functional neurological disorder in people with long COVID: A systematic review” Alexandra Kachaner, Cédric Lemogne, Brigitte Ranque, Elodie Meppiel, Thomas de Broucker
33 [GO] 2023―May―25 Ocrelizumab extended interval dosing in multiple sclerosis during SARS-CoV -2 pandemic: a real-world experience Simone Guerrieri, Chiara Bucca, Agostino Nozzolillo, Angela Genchi, Chiara Zanetta, Ilaria Cetta, et al. (+6)
34 [GO] 2023―May―15 New-onset functional tics during the COVID -19 pandemic: clinical characteristics of 105 cases from a single centre Andrea E. Cavanna, Giulia Purpura, Anna Riva, Renata Nacinovich, Stefano Seri
35 [GO] 2023―May―10 History of cerebrovascular disease but not dementia increases the risk for secondary vascular events during SARS-CoV -2 infection with presumed Omicron variant: a retrospective observational study Christina Mayer, Marcel S. Woo, Thomas Theo Brehm, Andreas Heyer, Marlene Fischer, Felix Fischbach, et al. (+6)
36 [GO] 2023―May―08 Antibody response elicited by the SARS-CoV -2 vaccine booster in patients with multiple sclerosis: who gains from it? Irene Schiavetti, Matilde Inglese, Jessica Frau, Elisabetta Signoriello, Francesca Caleri, Maria Laura Stromillo, et al. (+17)
37 [GO] 2023―Mar―31 Risk of disease relapse, safety and tolerability of SARS-CoV -2 vaccination in patients with chronic inflammatory neuropathies Pietro Emiliano Doneddu, Chiara Briani, Dario Cocito, Fiore Manganelli, Gian Maria Fabrizi, Sabrina Matà, et al. (+38)
38 [GO] 2023―Mar―15 Impact of the COVID -19 pandemic on clinical autonomic practice in Europe A survey of the European Academy of Neurology ( EAN ) and the European Federation of Autonomic Societies ( EFAS ) Alessandra Fanciulli, Fabian Leys, Magdalena Krbot Skorić, Diogo Reis Carneiro, Giovanna Calandra-Buonaura, Jennifer Camaradou, et al. (+22)
39 [GO] 2023―Feb―18 Long COVID : Does Sars-Cov -2 induce lingering brain lesions ? Jacques Hugon
40 [GO] 2023―Jan―28 Cardiovascular Autonomic Dysfunction - a cause of acute Covid-19 complications and persistent post-Covid -19 complaints? Max J. Hilz
41 [GO] 2022―Nov―21 Mass ‘psychogenic transient loss of consciousness’ after COVID-19 vaccination Diogo Reis Carneiro, Rui Araújo
42 [GO] 2022―Nov―01 SARS-CoV-2-vaccines and neurologic diseases: Cause or coincidence? Peter Berlit
43 [GO] 2022―Oct―19 Neurological autoimmune diseases following vaccinations against SARS-CoV -2: a follow-up study Sofia Doubrovinskaia, Christoph Mooshage, Corinna Seliger, Hanns-Martin Lorenz, Simon Nagel, Pascal Lehnert, et al. (+6)
44 [GO] 2022―Sep―10 Signs and symptoms of Covid-19 in patients with multiple sclerosis Irene Schiavetti, Luca Carmisciano, Marta Ponzano, Cinzia Cordioli, Eleonora Cocco, Girolama Alessandra Marfia, et al. (+21)
45 [GO] 2022―Sep―03 Subtle vascular and astrocytic changes in the brain of COVID-19 patients Gabriela Camelia Rosu, Valentin Octavian Mateescu, Alexandra Simionescu, Anca-Maria Istrate-Ofiteru, George Cristian Curcă, Ionica Pirici, et al. (+5)
46 [GO] 2022―Sep―03 Vestibular syndromes after COVID-19 vaccination: a prospective cohort study Johannes Gerb, Sandra Becker-Bense, Andreas Zwergal, Doreen Huppert
47 [GO] 2022―Jul―16 Incidence of Guillain-Barré syndrome following SARS-CoV -2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines Miguel García-Grimshaw, Javier Andrés Galnares-Olalde, Omar Yaxmehen Bello-Chavolla, Anaclara Michel-Chávez, Arturo Cadena-Fernández, María Eugenia Briseño-Godínez, et al. (+17)
48 [GO] 2022―Jul―16 Risk of SARS-CoV -2 infection, hospitalization and death for COVID -19 in people with Parkinson’s disease or parkinsonism over a 15-month period: a cohort study Corrado Zenesini, Luca Vignatelli, Laura Maria Beatrice Belotti, Flavia Baccari, Giovanna Calandra-Buonaura, Pietro Cortelli, et al. (+13)
49 [GO] 2022―Jul―09 B cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV -2 vaccine efficacy in anti-CD20 -treated multiple sclerosis patients Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, Sophia Hober, Peter Nilsson, Chiara Starvaggi Cucuzza, et al. (+4)
50 [GO] 2022―Jul―06 Impact of vaccination on COVID-19 outcome in multiple sclerosis Gabriel Bsteh, Christiane Gradl, Bettina Heschl, Harald Hegen, Franziska Di Pauli, Hamid Assar, et al. (+39)
51 [GO] 2022―Apr―28 Surge of Bell’s Palsy in the era of COVID-19; Systematic review S Gupta, MK Jawanda
52 [GO] 2022―Apr―23 COVID-19 vaccination hesitancy among people with chronic neurological disorders: a position paper Martin Rakusa, Serefnur Öztürk, Elena Moro, Raimund Helbok, Claudio L. Bassetti, Ettore Beghi, et al. (+18)
53 [GO] 2022―Apr―16 Shoulder palsy following SARS-CoV2 infection: 2 cases of typical Parsonage-Turner syndrome Etienne Fortanier, Thomas Le Corroller, Marie Hocquart, Emilien Delmont, Shahram Attarian
54 [GO] 2022―Apr―09 COVID-19 did not result in increased hospitalization for stroke and transient ischemic attack. A nationwide study Claus Z. Simonsen, Rolf A. Blauenfeldt, Jakob N. Hedegaard, Christina Kruuse, David Gaist, Troels Wienecke, et al. (+3)
55 [GO] 2022―Apr―07 Safety and tolerability of SARS-Cov2 vaccination in patients with myasthenia gravis: a multicenter experience Antonio Farina, Silvia Falso, Sara Cornacchini, Gregorio Spagni, Gabriele Monte, Alice Mariottini, et al. (+4)
56 [GO] 2022―Mar―25 Guilty by association? SARS-Cov2 antibodies and MOGAD Radu Tanasescu, Markus Reindl
57 [GO] 2022―Mar―14 One-Year Cognitive Follow-Up of COVID-19 Hospitalized Patients Roberta Ferrucci, Michelangelo Dini, Chiara Rosci, Antonella Capozza, Elisabetta Groppo, Maria R. Reitano, et al. (+11)
58 [GO] 2022―Mar―03 Neurological outcomes one year after COVID-19 diagnosis: a prospective longitudinal cohort study Verena Rass, Ronny Beer, Alois Josef Schiefecker, Anna Lindner, Mario Kofler, Bogdan Ianosi, et al. (+22)
59 [GO] 2022―Feb―28 Is there a correlation between MOGAD and SARS-CoV-2 infection? Sara Mariotto, Sara Carta, Alessandro Dinoto, Giuseppe Lippi, Gian Luca Salvagno, Laura Masin, et al. (+3)
60 [GO] 2022―Feb―23 Short- and long-term outcome and predictors in an international cohort of patients with neuro COVID-19 Ettore Beghi, Raimund Helbok, Serefnur Oztturk, Omer Karadas, Vitalie Lisnic, Oxana Grosu, et al. (+58)
61 [GO] 2022―Feb―09 Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID-19 Paola Ortelli, Davide Ferrazzoli, Luca Sebastianelli, Roberto Maestri, Sabrina Dezi, Danny Spampinato, et al. (+8)
62 [GO] 2022―Feb―01 Comparing humoral immune response to SARS-CoV2 vaccines in multiple sclerosis and healthy controls: an Austrian prospective multi-center cohort study Gabriel Bsteh, Harald Hegen, Gerhard Traxler, Nik Krajnc, Fritz Leutmezer, Franziska Di Pauli, et al. (+12)
63 [GO] 2021―Dec―23 The Impact of the COVID-19 Pandemic on Creutzfeldt-Jakob Disease Surveillance and Patient Care in the United Kingdom N Watson, J Kirby, H Kurudzhu, M Leitch, J MacKenzie, B Smith-Bathgate, et al. (+4)
64 [GO] 2021―Dec―20 Motor and respiratory decline in patients with Late-onset Pompe disease after cessation of enzyme replacement therapy during COVID-19 pandemic Céline Tard, Emmanuelle Salort-Campana, Maud Michaud, Marco Spinazzi, Aleksandra Nadaj Pakleza, Hélène Durr, et al. (+54)
65 [GO] 2021―Dec―17 The relationship between COVID-19 and movement disorders: a narrative review Susanne A. Schneider, Anita Hennig, Davide Martino
66 [GO] 2021―Dec―17 Cognitive sequelae of long COVID may not be permanent. A prospective study Oscar H. Del Brutto, Denisse A. Rumbea, Bettsy Y. Recalde, Robertino M. Mera
67 [GO] 2021―Dec―11 Association of the COVID-19 Outbreak with Acute Stroke Care in Switzerland Gian Marco De Marchis, Patrick R. Wright, Patrik Michel, Davide Strambo, Emmanuel Carrera, Elisabeth Dirren, et al. (+32)
68 [GO] 2021―Nov―30 Ischemic stroke in COVID-19 patients: mechanisms, treatment and outcomes in a consecutive Swiss Stroke Registry analysis Davide Strambo, Gian Marco De Marchis, Leo H. Bonati, Marcel Arnold, Emmanuel Carrera, Santi Galletta, et al. (+31)
69 [GO] 2021―Nov―04 The effect of air pollution on Covid-19 severity in a sample of patients with Multiple Sclerosis Roberto Bergamaschi, Marta Ponzano, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli, Massimo Filippi, et al. (+23)
70 [GO] 2021―Oct―26 Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival Michala Jakubikova, Michaela Tyblova, Adam Tesar, Magda Horakova, Daniela Vlazna, Irena Rysankova, et al. (+6)
71 [GO] 2021―Oct―20 A fatal case of COVID-19-associated acute necrotizing encephalopathy Dace Ziemele, Gundega Ķauķe, Krista Skrējāne, Līga Jaunozoliņa, Guntis Karelis
72 [GO] 2021―Oct―20 Cerebral venous sinus thrombosis associated with COVID-19 vaccine-induced thrombocytopenia: Improvement in mortality rate over time Barbara Casolla, Charlotte Cordonnier
73 [GO] 2021―Oct―20 Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series Leon D. Kaulen, Sofia Doubrovinskaia, Christoph Mooshage, Berit Jordan, Jan Purrucker, Carmen Haubner, et al. (+7)
74 [GO] 2021―Oct―11 Stroke mortality during the second wave of the COVID-19 pandemic. Is it getting any better? Aristeidis H. Katsanos, Georgios Tsivgoulis
75 [GO] 2021―Sep―29 Comment on “ Predictive factors for a severe course of COVID-19 infection in Myasthenia gravis patients with an overall impact on myasthenic status and survival “ by JakubíKová et al Giuliana Galassi, Alessandro Marchioni
76 [GO] 2021―Sep―27 Vessel Wall Magnetic Resonance Imaging in Covid-19 associated Cryptogenic Ischemic Stroke Federico Mazzacane, Antonio Zito, Serena Magno, Alessandra Persico, Valentina Mazzoleni, Carlo Asteggiano, et al. (+5)
77 [GO] 2021―Sep―18 Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination Anita van de Munckhof, Katarzyna Krzywicka, Diana Aguiar de Sousa, Mayte Sánchez van Kammen, Mirjam R. Heldner, Katarina Jood, et al. (+9)
78 [GO] 2021―Sep―16 Fewer COVID-19-associated strokes and reduced severity during the second COVID-19 wave. The madrid stroke network Blanca Fuentes, María Alonso de Leciñana, Ricardo Rigual, Sebastián García-Madrona, Fernando Díaz-Otero, Clara Aguirre, et al. (+18)
79 [GO] 2021―Sep―15 Clinical and radiological features of severe acute respiratory syndrome coronavirus 2 meningo-encephalitis Gabriel R. Freitas, Marcos Ravi Figueiredo, Arthur Vianna, Carlos Otávio Brandão, Helio M. Torres-Filho, Andrea F. A. Martins, et al. (+2)
80 [GO] 2021―Aug―31 Lessons learned from patients with neurological diseases at the time of COVID-19: the EFNA-EAN survey B Bodini, E Moro, J Jaarsma, E Cunningham, J Sellner, D Walsh, et al. (+24)
81 [GO] 2021―Aug―31 The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2 Keith W Muir, Richard J Perry
82 [GO] 2021―Aug―26 Headache with SARS-CoV-2 infection: A matter of concern Lukas Dearing, Felix Müller, Johann Sellner
83 [GO] 2021―Aug―19 Neurological symptoms and complications in predominantly hospitalized COVID-19 patients - results of the European multinational LEOSS registry Nina N. Kleineberg, Samuel Knauss, Eileen Gülke, Hans O. Pinnschmidt, Carolin E. M. Jakob, Paul Lingor, et al. (+25)
84 [GO] 2021―Aug―09 A Full Year of the COVID-19 Pandemic with Two Infection Waves and its Impact on Ischemic Stroke Patient Care in Germany Daniel Richter, Jens Eyding, Ralph Weber, Dirk Bartig, Armin Grau, Werner Hacke, Christos Krogias
85 [GO] 2021―Aug―02 Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review Giuseppe Cosentino, Massimiliano Todisco, Noy Hota, Giovanni Della Porta, Patrizia Morbini, Cristina Tassorelli, Antonio Pisani
86 [GO] 2021―Jul―30 Headache as an acute and post COVID-19 Symptom in COVID-19 Survivors: A Meta-analysis of the Current Literature César Fernández-de-las-Peñas, Marcos Navarro-Santana, Víctor Gómez-Mayordomo, María L. Cuadrado, David García-Azorín, Lars Arendt-Nielsen, Gustavo Plaza-Manzano
87 [GO] 2021―Jul―22 Rapid Onset of Functional Tic-Like Behaviours in Young Adults during the COVID-19 Pandemic Tamara Pringsheim, Davide Martino
88 [GO] 2021―Jul―21 Safety of the BNT162b2 COVID-19 vaccine in Multiple Sclerosis: Early experience from a tertiary MS Center in Israel Itay Lotan, Adi Wilf-Yarkoni, Yitzhak Friedman, Hadas Stiebel-Kalish, Israel Steiner, Mark A. Hellmann
89 [GO] 2021―Jul―05 COVID-19 and ischemic stroke Dimitrios Sagris, Aikaterini Papanikolaou, Alexandra Kvernland, Eleni Korompoki, Jennifer A. Frontera, Andrea B. Troxel, et al. (+6)
90 [GO] 2021―Jun―22 Predictive factors of smell recovery in a clinical series of 288 COVID-19 patients with olfactory dysfunction Sven Saussez, Shilpee Sharma, Anaïs Thiriad, Véronique Olislagers, Inès Vu Duc, Serge-D. Le Bon, et al. (+7)
91 [GO] 2021―Jun―21 Risk and outcomes of covid-19 in patients with multiple sclerosis Irene Moreno-Torres, Virginia Meca Lallana, Lucienne Costa-Frossard, Celia Oreja-Guevara, Clara Aguirre, Elda María Alba Suárez, et al. (+22)
92 [GO] 2021―Jun―11 Persistent visual dysfunction following PRES due to COVID-19: Case series and literature review Alison M. Hixon, Ashesh A. Thaker, Victoria S. Pelak
93 [GO] 2021―Jun―03 Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival Jakubikova Michala, Tyblova Michaela, Tesar Adam, Horakova Magda, Vlazna Daniela, Rysankova Irena, et al. (+6)
94 [GO] 2021―Jun―01 Systematic Review of Cases of Acute Myelitis in Individuals with COVID-19 Eva C. Schulte, Larissa Hauer, Alexander B. Kunz, Johann Sellner
95 [GO] 2021―May―28 Importance of physical activity during and after the SARS-CoV-2 / COVID-19 pandemic: a strategy for women to cope with stress. Anna Vittoria Mattioli, Francesca Coppi, Sabina Gallina
96 [GO] 2021―May―25 COVID-19: An unforgettable challenge for the neurology community Elena Moro, Pille Taba
97 [GO] 2021―May―15 Headache teleconsultation in the era of COVID-19: patients’ evaluation and future directions Leonor Dias, Bárbara Martins, Maria João Pinto, Ana Luísa Rocha, Madalena Pinto, Andreia Costa
98 [GO] 2021―May―13 Encephalitis as Neurological Complication of COVID-19: A Systematic Review and Meta Analysis of Incidence, Outcomes and Predictors Isabel Siow, Keng Siang Lee, John J.Y. Zhang, Seyed Ehsan Saffari, Adeline Ng
99 [GO] 2021―May―13 Factors associated with COVID-19 in people with Parkinson’s disease: a systematic review and meta-analysis Diego Chambergo-Michilot, Shamir Barros-Sevillano, Oscar Rivera-Torrejón, Gabriel A. De la Cruz-Ku, Nilton Custodio
100 [GO] 2021―May―09 SARS-COV2 vaccine-related neurological complications need large collaborative studies, not single case reports or small descriptive series Didier Leys, Mark Edwards, Kristl Vonck, Pille Taba, Elena Moro, Andrew Chan, Claudia Sommer
101 [GO] 2021―Apr―26 Rhinorrhea following SARS-CoV-2 nasopharyngeal swab: a case for beta-2 transferrin testing Julian Perneczky, Csilla Neuchrist, Johann Sellner
102 [GO] 2021―Apr―25 Impact of the COVID-19 pandemic on access to health care services among patients with Multiple Sclerosis in the Lazio region, Italy Paola Colais, Silvia Cascini, Maria Balducci, Nera Agabiti, Marina Davoli, Danilo Fusco, et al. (+2)
103 [GO] 2021―Apr―10 Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: a systematic review and meta-analysis Lina Palaiodimou, Maria-Ioanna Stefanou, Aristeidis H. Katsanos, Paraskevi C. Fragkou, Marianna Papadopoulou, Christos Moschovos, et al. (+8)
104 [GO] 2021―Mar―29 Acute stroke care during the COVID-19 pandemic Visnja Padjen
105 [GO] 2021―Mar―19 Impact of the COVID-19 pandemic and a national lockdown on hospitalisation for stroke and related 30-day mortality in France: a nationwide observational study Amélie Gabet, Clémence Grave, Philippe Tuppin, Edouard Chatignoux, Yannick Béjot, Valérie Olié
106 [GO] 2021―Mar―17 Response to: “MuSK-positive myasthenia may not only triggered by SARS-CoV-2” Andrea Assini, Ilaria Gandoglia, Valentina Damato, Klaudio Rikani, Amelia Evoli, Massimo Del Sette
107 [GO] 2021―Mar―10 Gender issues during the times of Covid-19 pandemic Wolfgang Grisold, Elena Moro, Maria Teresa Ferretti, Anne Hege Aamodt, Gennarina Arabia, Elena R. Lebedeva, et al. (+12)
108 [GO] 2021―Mar―10 MuSK-positive myasthenia may not only be triggered by SARS-CoV-2 Josef Finsterer, Fulvio Alexandre Scorza
109 [GO] 2021―Mar―08 Neurological outcome and quality of life three months after COVID-19: a prospective observational cohort study Verena Rass, Ronny Beer, Alois Josef Schiefecker, Mario Kofler, Anna Lindner, Philipp Mahlknecht, et al. (+16)
110 [GO] 2021―Feb―23 Impact of the COVID-19 pandemic on stroke teleconsultations in Germany in the first half of 2020 Christoph Vollmuth, Olga Miljukov, Mazen Abu-Mugheisib, Anselm Angermaier, Jessica Barlinn, Loraine Busetto, et al. (+25)
111 [GO] 2021―Feb―18 Chronic severe methanol intoxication after repeated mask cleansing for fear to COVID-19 - a new risk of coronaphobia Markel Erburu-Iriarte, Patricia Rodrigo-Armenteros, Iñigo Oyarzun-Irazu, Ines Aranzabal-Alustiza, Saul Silvarrey-Rodriguez, Lander Antón-Méndez, Juan Carlos García-Moncó
112 [GO] 2021―Feb―12 Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection. A longitudinal prospective study nested to a population cohort. Oscar H. Del Brutto, Shasha Wu, Robertino M. Mera, Aldo F. Costa, Bettsy Y. Recalde, Naoum P. Issa
113 [GO] 2021―Jan―25 Acute cerebellar ataxia and myoclonus with or without opsoclonus: a parainfectious syndrome associated with COVID-19 Cendrine Foucard, Aurore San-Galli, Clément Tarrano, Hugo Chaumont, Annie Lannuzel, Emmanuel Roze
114 [GO] 2021―Jan―22 Meningitis due to CSF leak after Nasal Swab Testing for Covid-19 FJ Alberola-Amores, E Valdeolivas-Urbelz, M Torregrosa-Ortiz, M Álvarez-Sauco, J. Alom-Poveda
115 [GO] 2021―Jan―21 Neurological complications of COVID-19 in hospitalized patients: The registry of a neurology department in the first wave of the pandemic Sofía Portela-Sánchez, Antonio Sánchez-Soblechero, Pedro José Melgarejo Otalora, Ángela Rodríguez López, Gabriel Velilla Alonso, Michael Armando Palacios-Mendoza, et al. (+11)
116 [GO] 2021―Jan―21 Delivering telemedicine consultations for patients with Transient Ischemic Attack during the COVID-19 pandemic in a comprehensive tertiary stroke centre in the United Kingdom. Lucio D’Anna, Natalya Ellis, Paul Bentley, Zoe Brown, Omid Halse, Sohaa Jamil, et al. (+6)
117 [GO] 2021―Jan―18 Parkinson Patients’ needs during COVID-19 pandemic in a red zone: a Framework Analysis of Open-Ended Survey Questions Francesco Cavallieri, Francesca Sireci, Valentina Fioravanti, Giulia Toschi, Vittorio Rispoli, Francesca Antonelli, et al. (+3)
118 [GO] 2021―Jan―18 A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: the NeuroCOVID-19 task Force of the european Academy of neurology Johann Sellner, Thomas M. Jenkins, Tim J. von Oertzen, Claudio L. Bassetti, Ettore Beghi, Daniel Bereczki, et al. (+19)
119 [GO] 2021―Jan―15 Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection Andrea Assini, Ilaria Gandoglia, Valentina Damato, Klaudio Rikani, Amelia Evoli, Massimo Del Sette
120 [GO] 2021―Jan―15 Cerebral venous thrombosis and SARS-CoV-2 infection: a systematic review and meta-analysis Tommaso Baldini, Gian Maria Asioli, Michele Romoli, Mariana Carvalho Dias, Eva C. Schulte, Larissa Hauer, et al. (+3)
121 [GO] 2021―Jan―13 Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: a case-control study Alicia Gonzalez-Martinez, Víctor Fanjul, Carmen Ramos, Jorge Serrano Ballesteros, Marta Bustamante, Almudena Villa Martí, et al. (+4)
122 [GO] 2021―Jan―02 Primary prevention of COVID-19: advocacy for vaccination from a neurological perspective Johann Sellner, Tom Jenkins, Tim von Oertzen, Claudio L. Bassetti, Ettore Beghi, Daniel Bereczki, et al. (+19)
123 [GO] 2020―Dec―30 Differential Effects of SARS-CoV-2 Pandemic on Patients Presenting to a Neurological Emergency Room Depending on Their Triage Score in an Area with low COVID-19 Incidence Margit Millan, Simon Nagel, Christoph Gumbinger, Loraine Busetto, Jan C. Purrucker, Christian Hametner, et al. (+2)
124 [GO] 2020―Dec―28 Biomarkers for CNS injury in CSF are elevated in COVID-19 and associated with neurological symptoms and disease severity Johan Virhammar, Anja Nääs, David Fällmar, Janet L. Cunningham, Andrea Klang, Nicholas J. Ashton, et al. (+7)
125 [GO] 2020―Dec―25 Perceived stress and social support in a large population of people with Multiple Sclerosis recruited online through COVID 19 pandemic. Simona Bonavita, Maddalena Sparaco, Antonio Russo, Giovanna Borriello, Luigi Lavorgna
126 [GO] 2020―Dec―24 Neurology training and research in the Covid-19 pandemic: A survey of the Resident and Research Fellow Section of the European Academy of Neurology Luca Cuffaro, Vanessa Carvalho, Giovanni Di Liberto, Lisa Klinglehoefer, Anna Sauerbier, David Garcia-Azorin, et al. (+4)
127 [GO] 2020―Dec―19 COVID-19 in MS patients: susceptibility, severity risk factors and serological response Ana Zabalza, Simón Cárdenas-Robledo, Paula Tagliani, Georgina Arrambide, Susana Otero-Romero, Pere Carbonell-Mirabent, et al. (+15)
128 [GO] 2020―Dec―09 Greater decline of acute stroke admissions compared with acute coronary syndromes during COVID-19 outbreak in Greece: Cerebro/Cardiovascular implications amidst a second wave surge Christos Katsouras, Theodoros Karapanayiotides, Michail Papafaklis, Sotirios Giannopoulos, Antonios Ziakas, George Sianos, et al. (+7)
129 [GO] 2020―Nov―21 The EAN COVID-19 registry (ENERGY): An international instrument for surveillance of neurological complications in patients with COVID-19 Ettore Beghi, Raimund Helbok, Michael Crean, Sherry Hsiang-Yi Chou, Molly McNett, Elena Moro, et al. (+21)
130 [GO] 2020―Nov―13 The Impact of the COVID-19 outbreak on acute stroke care in Slovakia (data from across the country) Zuzana Gdovinová, Marianna Vitková, Anna Baráková, Alena Cvopová
131 [GO] 2020―Oct―26 Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders Céline Louapre, Elisabeth Maillart, Caroline Papeix, Sinead Zeidan, Damien Biotti, Zoé Lepine, et al. (+13)
132 [GO] 2020―Oct―15 EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic T. J. von Oertzen, A. Macerollo, M. A. Leone, E. Beghi, M. Crean, S. Oztuk, et al. (+21)
133 [GO] 2020―Oct―12 COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management Teresa Costabile, Antonio Carotenuto, Luigi Lavorgna, Giovanna Borriello, Lucia Moiola, Matilde Inglese, et al. (+14)
134 [GO] 2020―Oct―09 Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown Tobias Zrzavy, Isabella Wimmer, Paulus S. Rommer, Thomas Berger
135 [GO] 2020―Sep―30 Bilateral Facial Nerve Palsy associated with COVID-19 and Epstein-Barr Virus co-infection Antonio Cabrera Muras, María del Mar Carmona-Abellán, Alejandra Collía Fernández, Juan María Uterga Valiente, Lander Antón Méndez, Juan Carlos García-Moncó
136 [GO] 2020―Sep―30 Muscle involvement in SARS-CoV-2 infection Lea Pitscheider, Mario Karolyi, Francesco R. Burkert, Raimund Helbok, Julia V. Wanschitz, Corinne Horlings, et al. (+12)
137 [GO] 2020―Sep―27 COVID-19 meningitis without pulmonary involvement with positive cerebrospinal fluid PCR Zohre Khodamoradi, Seyed Ali Hosseini, Mohammad Hassan Gholampoor Saadi, Zeinab Mehrabi, Mohammad Reza Sasani, Sholeh Yaghoubi
138 [GO] 2020―Sep―26 Multiple sclerosis and COVID-19: how many are at risk? Gabriel Bsteh, Christina Bitschnau, Harald Hegen, Michael Auer, Franziska Di Pauli, Paulus Rommer, et al. (+2)
139 [GO] 2020―Sep―26 Response to: SARS-CoV-2 associated Guillain-Barré syndrome in 62 patients Pietro Emiliano Doneddu, Paolo De Sanctis, Luca Viganò, Carlo Selmi, Francesco Gentile, Eduardo Nobile-Orazio
140 [GO] 2020―Sep―26 SARS-CoV-2 associated Guillain-Barre syndrome in 62 patients J. Finsterer, FA. Scorza, AC. Fiorini
141 [GO] 2020―Sep―25 Increased risk of acute stroke among patients with severe COVID-19: a multicenter study and meta-analysis Timo Siepmann, Annahita Sedghi, Erik Simon, Simon Winzer, Jessica Barlinn, Katja de With, et al. (+16)
142 [GO] 2020―Sep―23 COVID-19 provoking Guillain-Barrè Syndrome: the Bergamo case series Camillo Foresti, Maria Cristina Servalli, Barbara Frigeni, Nicola Rifino, Benedetta Storti, Paolo Gritti, et al. (+3)
143 [GO] 2020―Sep―21 Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid-19 Manuel Cappellari, Andrea Zini, Davide Sangalli, Anna Cavallini, Monica Reggiani, Federica Nicoletta Sepe, et al. (+15)
144 [GO] 2020―Sep―17 Olfactory bulb and mucosa abnormalities in persistent COVID-19 induced anosmia: a Magnetic Resonance Imaging study Georgios Tsivgoulis, Paraskevi C. Fragkou, Stefanos Lachanis, Lina Palaiodimou, Vaia Lambadiari, Matilda Papathanasiou, et al. (+3)
145 [GO] 2020―Sep―06 Effects of Covid-19 outbreak on stroke admissions in Brescia, Lombardy, Italy Alberto Benussi, Enrico Premi, Andrea Pilotto, Ilenia Libri, Alessandro Pezzini, Ciro Paolillo, et al. (+3)
146 [GO] 2020―Aug―28 Cytokine release syndrome-associated encephalopathy in patients with COVID-19 Peggy Perrin, Nicolas Collongues, Seyyid Baloglu, Dimitri Bedo, Xavier Bassand, Thomas Lavaux, et al. (+7)
147 [GO] 2020―Aug―28 Facial nerve palsy: an atypical clinical manifestation of COVID-19 infection in a family cluster Céline Derollez, Tifanie Alberto, Iracema Leroi, Marie-Anne Mackowiak, Yaohua Chen
148 [GO] 2020―Aug―16 Covid-19-related encephalopathy: a case series with brain FDG-PET/CT findings Cécile Delorme, Olivier Paccoud, Aurélie Kas, Adèle Hesters, Stéphanie Bombois, Pauline Shambrook, et al. (+11)
149 [GO] 2020―Aug―13 Movement disorders as a new neurological clinical picture in severe SARS-CoV-2 infection Paulina Cunha, Bastien Herlin, Kosta Vassilev, Aurelie Kas, Stephane Lehericy, Yulia Worbe, et al. (+3)
150 [GO] 2020―Aug―12 Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement Makbule Senel, Samir Abu-Rumeileh, Detlef Michel, Tamara Garibashvili, Katharina Althaus, Jan Kassubek, Markus Otto
151 [GO] 2020―Aug―06 Impact of COVID-19 outbreak in reperfusion therapies of acute ischemic stroke in North-West Spain Herbert Tejada Meza, Álvaro Lambea Gil, Agustín Sancho Saldaña, Maite Martínez-Zabaleta, Eñaut Garmendia Lopetegui, Elena López-Cancio Martínez, et al. (+28)
152 [GO] 2020―Aug―06 Large vessel stroke in six patients following SARS-CoV-2 infection: a retrospective case study series of acute thrombotic complications on stable underlying atherosclerotic disease Bertrand Lapergue, Aïcha Lyoubi, Elena Meseguer, Ioan Avram, Christian Denier, laura Venditti, et al. (+8)
153 [GO] 2020―Aug―05 Guillain Barré Syndrome associated with SARS-CoV-2 infection. A Systematic Review Paolo De Sanctis, Pietro Emiliano Doneddu, Luca Viganò, Carlo Selmi, Eduardo Nobile-Orazio
154 [GO] 2020―Jul―29 A special issue on SARS-CoV-2 Didier Leys
155 [GO] 2020―Jul―18 Assessment of neurological manifestations in hospitalized patients with COVID-19 Marco Luigetti, Raffaele Iorio, Anna Rita Bentivoglio, Luca Tricoli, Vittorio Riso, Jessica Marotta, et al. (+375)
156 [GO] 2020―Jul―17 Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak Carlos M. Chiesa-Estomba, Jerome R. Lechien, Thomas Radulesco, Justin Michel, Leigh J Sowerby, Claire Hopkins, Sven Saussez
157 [GO] 2020―Jul―17 Neurology practice during the COVID-19 outbreak and post-pandemic era: experiences and challenges Yi Tang, Yi Xing, Lili Cui, Chuanjie Wu, Xinmei Wen, Haiqing Song, et al. (+5)
158 [GO] 2020―Jul―15 Sever acute respiratory syndrome coronavirus-2 may be an underappreciated pathogen of the central nervous system S.B. Alam, Steven Willows, Marianna Kulka, Jagdeep K. Sandhu
159 [GO] 2020―Jun―20 Neurosonology during the COVID-19 pandemic (Editorial commentary from the chairs of the ultrasound panel of the EAN) David Skoloudik, Milija Mijajlovic
160 [GO] 2020―Jun―17 The international EAN survey on neurological symptoms in patients with COVID-19 infection E. Moro, A. Priori, E. Beghi, R. Helbok, L. Campiglio, C.L. Bassetti, et al. (+20)
161 [GO] 2020―Jun―17 Stroke care in Europe during the COVID-19 pandemic Diana Aguiar de Sousa, H. Bart van der Worp
162 [GO] 2020―Jun―13 Guillain-Barré syndrome after SARS-CoV-2 infection Duygu Kilinc, Suzanne van de Pasch, Alex Y. Doets, Bart C. Jacobs, Judith van Vliet, Marcel P.J. Garssen
163 [GO] 2020―Jun―12 Guillain-Barré syndrome in a patient with antibodies against SARS-COV-2 Raimund Helbok, Ronny Beer, Wolfgang Löscher, Sylvia Boesch, Markus Reindl, Rouven Hornung, et al. (+3)
164 [GO] 2020―Jun―11 What did we learn from the previous coronavirus epidemics and what can we do better: a neuroinfectiological point of view Tamar Akhvlediani, Ilijas Jelcic, Pille Taba, Bettina Pfausler, Israel Steiner, Johann Sellner
165 [GO] 2020―Jun―11 The impact of SARS-Cov-2 pandemic on stroke care: A warning message Anna Bersano, Leonardo Pantoni
166 [GO] 2020―Jun―05 Concomitant brain arterial and venous thrombosis in a COVID-19 patient Maria Malentacchi, Dario Gned, Valeria Angelino, Sara Demichelis, Alberto Perboni, Andrea Veltri, et al. (+2)
167 [GO] 2020―Jun―05 Miller-Fisher syndrome after SARS-CoV-2 infection José Antonio Reyes-Bueno, Lucía García-Trujillo, Patricia Urbaneja, Nicolás Lundahl Ciano-Petersen, María José Postigo-Pozo, César Martínez-Tomás, Pedro J Serrano-Castro
168 [GO] 2020―Jun―05 A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details Michele Romoli, Ilijas Jelcic, Raphaël Bernard-Valnet, David García Azorín, Luca Mancinelli, Tamar Akhvlediani, et al. (+3)
169 [GO] 2020―Jun―03 Stroke care during the Covid-19 pandemic: Experience from three large European countries Anna Bersano, Markus Kraemer, Emmanuel Touzé, Ralph Weber, Sonia Alamowitch, Igor Sibon, Leonardo Pantoni
170 [GO] 2020―Jun―01 SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with favorable outcome Agustina M. Lascano, Jean-Benoît Epiney, Matteo Coen, Jacques Serratrice, Raphaël Bernard-Valnet, Patrice H. Lalive, et al. (+2)
171 [GO] 2020―May―27 COVID-19 - neurologists stay aware! Tim J von Oertzen
172 [GO] 2020―May―27 Dysphagia in COVID-19 -multilevel damage to the swallowing network? Rainer Dziewas, Tobias Warnecke, Patrick Zürcher, Joerg C. Schefold
173 [GO] 2020―May―25 COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy Ana Carolina Andorinho de Freitas Ferreira, Tayla Taynan Romão, Yuri SIlva Macedo, Camila Pupe, Osvaldo JM Nascimento
174 [GO] 2020―May―25 Neuropsychiatric symptoms and quality of life in Spanish Alzheimer’s disease patients during COVID-19 lockdown B. Beatriz Lara, Anna Carnes, Farida Dakterzada, Ivan Benitez, Gerard Piñol-Ripoll
175 [GO] 2020―May―25 Lung ultrasonography in COVID-19: a gamechanger in the Stroke Unit? Carlo Lugnan, Valentina Tommasini, Giovanni Furlanis, Marcello Naccarato, Paola Caruso, Ilario Scali, et al. (+4)
176 [GO] 2020―May―25 Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study Álvaro Beltrán-Corbellini, Juan Luís Chico-García, Javier Martínez-Poles, Fernando Rodríguez-Jorge, Araceli Alonso-Cánovas
177 [GO] 2020―May―22 Letter to the Editor about the Beltrán-Corbellini et al . publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.) Jerome R. Lechien, Claire Hopkins, Sven Saussez
178 [GO] 2020―May―19 Practice recommendations for the neurovascular ultrasound investigations of acute stroke patients in the setting of COVID-19 pandemic: an expert consensus from the European Society of Neurosonology and Cerebral Hemodynamics C. Baracchini, A. Pieroni, M. Kneihsl, E. Azevedo, M. Diomedi, L. Pascazio, et al. (+8)
179 [GO] 2020―May―16 Ischaemic Stroke in the Time of Coronavirus Disease 2019 Herbert Tejada Meza, Álvaro Lambea Gil, Agustín Sancho Saldaña, Cristina Villar Yus, Beatriz Pardiñas Barón, Daniel Sagarra Mur, Javier Marta Moreno
180 [GO] 2020―May―16 Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2 Kristl Vonck, Ieme Garrez, Veerle De Herdt, Dimitri Hemelsoet, Guy Laureys, Robrecht Raedt, Paul Boon
181 [GO] 2020―May―13 Impact of the Covid-19 outbreak on acute stroke pathways - Insights from the Alsace region in France Raoul Pop, Véronique Quenardelle, Anca Hasiu, Dan Mihoc, Francois Sellal, Marie-Hélène Dugay, et al. (+7)
182 [GO] 2020―May―13 Disability through COVID-19 pandemic: Neurorehabilitation cannot wait Letizia Leocani, Karin Diserens, Marcello Moccia, Carlo Caltagirone
183 [GO] 2020―May―12 Covid-19 and neurodegeneration. What can we learn from the past? Emilia M Gatto, Julian Fernandez Bocazzi
184 [GO] 2020―May―08 Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection Raphaël Bernard-Valnet, Beatrice Pizzarotti, Angelica Anichini, Yoris Demars, Enrico Russo, Marie Schmidhauser, et al. (+3)
185 [GO] 2020―Apr―30 Emergency Room Neurology in times of COVID-19: Malignant Ischemic Stroke and SARS-COV2 Infection Tirso González-Pinto, Alain Luna-Rodríguez, Ana Moreno-Estébanez, Garazi Agirre-Beitia, Alfredo Rodríguez-Antigüedad, Marta Ruiz-Lopez
186 [GO] 2020―Apr―26 Of mice and men: COVID-19 challenges translational neuroscience Johann Sellner
187 [GO] 2020―Apr―25 COVID-19: what if the brain had a role in causing the deaths? C. Tassorelli, F. Mojoli, F. Baldanti, R. Bruno, M. Benazzo
188 [GO] 2020―Apr―25 Does SARS-Cov-2 invade the brain? Translational lessons from animal models Silvia Natoli, Vanessa Oliveira, Paolo Calabresi, Luis F. Maia, Antonio Pisani
189 [GO] 2020―Apr―23 The need for neurologists in the care of COVID-19 patients Johann Sellner, Pille Taba, Serefnur Öztürk, Raimund Helbok
190 [GO] 2020―Apr―22 Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study Álvaro Beltrán-Corbellini, Juan Luís Chico-García, Javier Martínez-Poles, Fernando Rodríguez-Jorge, Elena Natera-Villalba, Jorge Gómez-Corral, et al. (+9)
191 [GO] 2020―Apr―17 Lack of dyspnea in Covid-19 patients; another neurological conundrum? Bernat. Bertran Recasens, Juana Maria. Martinez-Llorens, Juan José. Rodriguez-Sevilla, Miguel Angel. Rubio
192 [GO] 2020―Mar―26 Novel coronavirus and central nervous system Tong Sun, Junwen Guan
 [1] 

192 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec